Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.
about
Efficacy and safety of metformin or oral contraceptives, or both in polycystic ovary syndromeReview of nonalcoholic fatty liver disease in women with polycystic ovary syndromeCLINICAL PRACTICE. Polycystic Ovary Syndrome.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelineFirst-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis.Polycystic ovary syndrome: chemical pharmacotherapy.Targets to treat androgen excess in polycystic ovary syndrome.Chronic Blockade of the Androgen Receptor Abolishes Age-Dependent Increases in Blood Pressure in Female Growth-Restricted RatsDevelopmental programming: rescuing disruptions in preovulatory follicle growth and steroidogenesis from prenatal testosterone disruption.Metformin in women with PCOS, cons.Metformin: risk-benefit profile with a focus on cancer.Long-term satisfaction and tolerability with low-dose flutamide: a 20-year surveillance study on 120 hyperandrogenic women.Chinese Herbal Medicine for the Optimal Management of Polycystic Ovary Syndrome.New Insights into mTOR Signal Pathways in Ovarian-Related Diseases: Polycystic Ovary Syndrome and Ovarian CancerHormonal contraception in women with polycystic ovary syndrome: choices, challenges, and noncontraceptive benefits.Population Pharmacokinetic and Pharmacodynamic Modeling of AZD4901 and Simulation to Support Dose Selection for the Phase 2a Study.Contemporary approaches to the management of polycystic ovary syndrome.Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and/or oral contraceptives in polycystic ovary syndrome
P2860
Q26781169-5E0A499A-3F5F-49D3-8658-48BFF8A96E29Q26828765-DA44A653-D206-4A0A-B0B8-38A88D2379D7Q29248890-7F7080EE-715E-4140-A91A-2182485A64C3Q33587845-AB0A2D8A-0BA5-41E2-9C7F-C3B22D8938EFQ34421386-CD61C13C-9DE3-4837-8F00-98833BC7E211Q35639510-C522C7AA-DBCC-4114-BCAB-61A0ABC70DCFQ35835501-36B0A5DC-1A89-409E-A8B0-745EFC2C9EFBQ36896680-DA1B729B-A398-4610-AB68-0E9C022065BEQ37054725-192EE3C6-A238-4D16-A742-6B1E63802397Q38245312-B6885BFA-76FC-4F29-9F6B-5D9F7C1595EAQ38584636-5F677C5C-DC59-4A9F-BB73-7DE6D21390D5Q39193966-26F5A5BA-EAC1-4C4D-B321-09B8AEB0A223Q39209037-1FFC1CCA-040D-480F-ACFF-2FB780ADB31DQ42144129-07E13C35-9828-4955-80AB-45319043DB96Q49540069-86D9E9A2-7C2A-4338-BC3D-C17AF596C739Q50906448-A93BD092-86F9-4BA0-B650-F6036DEC4389Q52606007-EF33AA34-E192-4CF1-A1B3-C26DD08530FCQ59315861-9CFF21D9-AE88-4535-97B2-2E36B51A5F8C
P2860
Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Adverse effects of the common ...... atic review and meta-analysis.
@ast
Adverse effects of the common ...... atic review and meta-analysis.
@en
Adverse effects of the common ...... atic review and meta-analysis.
@nl
type
label
Adverse effects of the common ...... atic review and meta-analysis.
@ast
Adverse effects of the common ...... atic review and meta-analysis.
@en
Adverse effects of the common ...... atic review and meta-analysis.
@nl
prefLabel
Adverse effects of the common ...... atic review and meta-analysis.
@ast
Adverse effects of the common ...... atic review and meta-analysis.
@en
Adverse effects of the common ...... atic review and meta-analysis.
@nl
P2093
P2860
P50
P356
P1476
Adverse effects of the common ...... atic review and meta-analysis.
@en
P2093
Amy T Wang
David Ehrmann
Gabriela Prutsky
Juan Pablo Domecq
Patricia J Erwin
Rebecca J Mullan
Vishnu Sundaresh
P2860
P304
P356
10.1210/JC.2013-2374
P407
P577
2013-10-03T00:00:00Z